Map
The PBAC cosmos
Every drug the PBAC has reviewed, projected onto a single plane. Drugs aren't placed by
therapy area or outcome — those labels were never given to the model. Each position is
learned from the text of the decisions alone; drugs that read like each other end up near
each other. Drag to pan, scroll to zoom, click a drug to see its neighbourhood.
Pneumococcal Conjugate Vaccine, 20-Valent — Other · Recommended · 2023 Pneumococcal Polysaccharide Conjugate Vaccine, 20-Valent — Other · Recommended · 2022 Abacavir Sulfate With Lamivudine — Infectious disease · Recommended · 2005 Abaloparatide — Endocrinology · Recommended · 2025 Abatacept — Other · Recommended · 2018 Abemaciclib — Oncology · Recommended · 2023 Abiraterone Acetate And Methylprednisolone — Oncology · Recommended · 2023 Abiraterone Acetate And Prednisolone — Oncology · Recommended · 2025 Abiraterone, Enzalutamide — Oncology · Not recommended · 2021 Abiraterone Acetate, Enzalutamide — Oncology · Recommended · 2021 Abiraterone Acetate — Oncology · Recommended · 2017 Abrocitinib — Other · Recommended · 2024 Acalabrutinib — Haematology · Recommended · 2025 Aciclovir — Other · Not recommended · 2021 Aclidinium Bromide — Respiratory · Recommended · 2014 Aclidinium Bromide Plus Eformoterol Fumarate Dihydrate — Respiratory · Recommended · 2015 Adalimumab — Other · Recommended · 2026 Influenza Vaccine, Adjuvanted — Other · Not recommended · 2019 Adrenaline — Other · Deferred · 2018 Adrenaline (Epinephrine) — Other · Recommended · 2026 Afatinib — Oncology · Recommended · 2013 Afatinib Dimaleate — Oncology · Not recommended · 2015 Aflibercept — Other · Recommended · 2025 Budesonide + Formoterol — Respiratory · Recommended · 2019 Alectinib, Crizotinib, Ceritinib — Oncology · Recommended · 2019 Alectinib — Oncology · Recommended · 2026 Alemtuzumab — Neurology · Not recommended · 2018 Alendronate Sodium — Other · Recommended · 2011 Alendronic Acid — Other · Recommended · 2016 Alglucosidase Alfa — Metabolic · Not recommended · 2013 Alirocumab — Cardiovascular · Recommended · 2023 Alogliptin With Metformin — Endocrinology · Recommended · 2013 Alogliptin — Endocrinology · Recommended · 2013 Amifampridine — Neurology · Recommended · 2022 Amino Acid Formula With Vitamins And Minerals Without Valine, Leucine And Isoleucine — Metabolic · Recommended · 2020 Amino Acid Formula With Vitamins And Minerals (Msud, Tyr, Hcu Coolers) — Metabolic · Recommended · 2018 Amino Acid Formula With Vitamins And Minerals Without Phenylalanine — Metabolic · Recommended · 2024 Amino Acid Formula With Vitamins And Minerals (Three Formulations: Without Phenylalanine; Without Phenylalanine And Tyrosine; Without Valine, Leucine And Isoleucine) — Metabolic · Recommended · 2015 Amino Acid Formula With Fat, Carbohydrate, Vitamins, Minerals, Trace Elements And Medium Chain Triglycerides — Metabolic · Recommended · 2024 Amino Acid Formula With Vitamins And Minerals Without Lysine And Low In Tryptophan — Metabolic · Recommended · 2024 Amino Acid Formula With Vitamins And Minerals Without Methionine — Metabolic · Recommended · 2020 Amino Acid Formula With Vitamins And Minerals Without Methionine And Supplemented With Arachidonic Acid And Docosahexaenoic Acid — Metabolic · Recommended · 2023 Amino Acid Formula With Vitamins And Minerals (Multiple Formulations) — Metabolic · Recommended · 2021 Amino Acid Formula With Vitamins And Minerals Without Methionine, Threonine And Valine And Low In Isoleucine — Metabolic · Recommended · 2024 Amino Acid Formula With Fat, Carbohydrate, Without Valine, Leucine And Isoleucine — Metabolic · Recommended · 2019 Amino Acid Formula With Vitamins And Minerals Without Valine, Leucine, Isoleucine, Supplemented With Arachidonic Acid And Docosahexaenoic Acid — Metabolic · Recommended · 2023 Amino Acid Formula Supplemented With Prebiotics, Probiotics And Long Chain Polyunsaturated Fatty Acids — Metabolic · Recommended · 2024 Amino Acid Formula With Vitamins And Minerals, Low Phenylalanine And Supplemented With Docosahexaenoic Acid And Arachidonic Acid — Metabolic · Recommended · 2019 Amino Acid Formula With Fat, Carbohydrate, Vitamins And Minerals Without Phenylalanine — Metabolic · Recommended · 2024 Amino Acid Formula With Carbohydrate Without Phenylalanine — Metabolic · Recommended · 2019 Amino Acid Formula With Vitamins And Minerals, Without Phenylalanine — Metabolic · Recommended · 2017 Amino Acid Formula With Vitamins, Minerals And Long Chain Polyunsaturated Fatty Acids Without Phenylalanine — Metabolic · Recommended · 2024 Amino Acid Formula With Vitamins, Minerals And Long Chain Polyunsaturated Fatty Acids, Without Phenylalanine — Metabolic · Recommended · 2018 Amino Acid Formula With Carbohydrate, Vitamins, Minerals And Trace Elements Without Phenylalanine, Supplemented With Docosahexaenoic Acid — Metabolic · Not recommended · 2020 Amino Acid Formula With Fat, Carbohydrate Without Phenylalanine And Tyrosine — Metabolic · Recommended · 2019 Amino Acid Formula With Vitamins And Minerals Without Phenylalanine And Tyrosine — Metabolic · Recommended · 2020 Amino Acid Formula With Vitamins And Minerals, Without Phenylalanine And Tyrosine, Supplemented With Arachidonic Acid And Docosahexaenoic Acid — Metabolic · Recommended · 2023 Amino Acid Formula (Multiple Formulations For Pku, Tyrosinaemia, Ga1, Mma/Pa, Hcu, Msud) — Metabolic · Recommended · 2020 Amino Acid Formula Without Phenylalanine — Metabolic · Recommended · 2016 Amino Acid Synthetic Formula Supplemented With Long Chain Polyunsaturated Fatty Acids, Medium Chain Triglycerides, 2'-Fucosyllactose And Lacto-N-Neotetraose — Metabolic · Recommended · 2022 Amino Acid Synthetic Formula Supplemented With Long Chain Polyunsaturated Fatty Acids — Metabolic · Recommended · 2023 Amino Acid Synthetic Formula — Metabolic · Recommended · 2015 Amino Acid Synthetic Formula Supplemented With Long Chain Polyunsaturated Fatty Acids; Amino Acid Formula Supplemented With Prebiotics, Probiotics And Long Chain Polyunsaturated Fatty Acids — Metabolic · Recommended · 2020 Amino Acid Synthetic Formula Supplemented With Long Chain Polyunsaturated Fatty Acids And Medium Chain Triglycerides — Other · Recommended · 2015 Amino Acids – Synthetic, Formula — Metabolic · Recommended · 2018 Amivantamab And Lazertinib — Oncology · Recommended · 2025 Amivantamab — Oncology · Recommended · 2026 Anakinra — Other · Not recommended · 2017 Anastrozole — Oncology · Recommended · 2005 Anifrolumab — Other · Recommended · 2024 Betaxolol, Bimatoprost, Bimatoprost + Timolol, Brimonidine, Brimonidine + Timolol, Brinzolamide, Brinzolamide + Timolol, Dorzolamide, Dorzolamide + Timolol, Latanoprost, Latanoprost + Timolol, Pilocarpine, Timolol, Travoprost, Timolol + Travoprost — Other · Recommended · 2015 Amoxicillin, Amoxicillin With Clavulanic Acid, Cefalexin, Doxycycline, Roxithromycin — Infectious disease · Recommended · 2019 Quetiapine — Other · Recommended · 2018 Antiretroviral Therapy (Art) — Combination Regimens — Infectious disease · Not recommended · 2013 Apalutamide — Oncology · Recommended · 2024 Apixaban — Cardiovascular · Recommended · 2015 Apomorphine — Neurology · Recommended · 2025 Apomorphine Hydrochloride — Neurology · Recommended · 2018 Apomorphine Hydrochloride Hemihydrate — Neurology · Recommended · 2018 Apremilast — Other · Recommended · 2023 Aprepitant — Oncology · Recommended · 2019 Arginine — Metabolic · Not recommended · 2017 Aripiprazole — Other · Recommended · 2025 Modafinil; Armodafinil — Neurology · Not recommended · 2020 Armodafinil — Neurology · Recommended · 2016 Arsenic Trioxide — Haematology · Not recommended · 2015 Asciminib — Haematology · Recommended · 2026 Asfotase Alfa Rch — Other · Not recommended · 2018 Asunaprevir — Other · Recommended · 2015 Atezolizumab — Oncology · Recommended · 2024 Atogepant — Neurology · Recommended · 2023 Ezetimibe + Atorvastatin — Cardiovascular · Recommended · 2014 Auranofin — Other · Recommended · 2017 Avacopan — Other · Not recommended · 2024 Avalglucosidase Alfa — Other · Recommended · 2021 Avatrombopag — Haematology · Recommended · 2022 Avelumab — Oncology · Recommended · 2022 Axitinib — Oncology · Recommended · 2014 Azacitidine — Haematology · Recommended · 2022 Baclofen — Neurology · Recommended · 2017 Balsalazide — Other · Recommended · 2017 Baricitinib — Other · Recommended · 2021 Beclometasone Dipropionate With Formoterol Fumarate Dihydrate — Respiratory · Recommended · 2024 Beclometasone Dipropionate With Formoterol Fumarate Dihydrate And Glycopyrronium — Respiratory · Recommended · 2022 Beclometasone Dipropionate With Formoterol Fumarate Dihydrate And Glycopyrronium Bromide — Respiratory · Recommended · 2020 Beclometasone With Formoterol — Respiratory · Recommended · 2022 Belantamab Mafodotin — Oncology · Recommended · 2025 Belimumab — Other · Recommended · 2020 Belzutifan — Oncology · Recommended · 2024 Bendamustine — Haematology · Recommended · 2015 Benralizumab — Respiratory · Recommended · 2020 Benzathine Benzylpenicillin — Infectious disease · Recommended · 2019 Benztropine Mesylate — Neurology · Recommended · 2015 Betaine — Metabolic · Recommended · 2014 Bevacizumab — Oncology · Recommended · 2024 Bezlotoxumab — Infectious disease · Not recommended · 2020 Bimatoprost — Other · Recommended · 2020 Bimekizumab — Other · Recommended · 2025 Biologics (Etanercept, Infliximab, Adalimumab, Ustekinumab, Secukinumab, Ixekizumab, Guselkumab, Tildrakizumab) — Other · Not recommended · 2020 Blinatumomab — Haematology · Recommended · 2024 Bortezomib — Oncology · Recommended · 2022 Botulinum Toxin Type A — Neurology · Recommended · 2019 Botulinum Toxin Type A Purified Neurotoxin Complex — Neurology · Recommended · 2019 Brentuximab Vedotin — Oncology · Recommended · 2025 Brexpiprazole — Other · Recommended · 2025 Brigatinib — Oncology · Not recommended · 2019 Brinzolamide/Brimonidine Tartrate — Other · Recommended · 2015 Brivaracetam — Neurology · Recommended · 2019 Pembrolizumab — Oncology · Not recommended · 2025 Brolucizumab — Other · Recommended · 2021 Budesonide / Glycopyrronium / Formoterol — Respiratory · Recommended · 2021 Budesonide With Formoterol — Respiratory · Recommended · 2023 Budesonide — Other · Recommended · 2024 Budesonide With Eformoterol Fumarate Dihydrate — Respiratory · Recommended · 2017 Budesonide With Glycopyrronium And Formoterol — Respiratory · Recommended · 2022 Bulevirtide — Other · Not recommended · 2025 Buprenorphine; Oxycodone + Naloxone — Other · Deferred · 2015 Buprenorphine — Other · Recommended · 2021 Buprenorphine With Naloxone — Other · Not recommended · 2020 Buprenorphine/Naloxone — Other · Recommended · 2019 Buprenorphine + Naloxone — Other · Recommended · 2014 Burosumab — Endocrinology · Recommended · 2022 Cabazitaxel — Oncology · Recommended · 2022 Cabotegravir — Infectious disease · Recommended · 2023 Cabotegravir And Rilpivirine — Infectious disease · Recommended · 2021 Cabozantinib — Oncology · Not recommended · 2025 Calcipotriol + Betamethasone Dipropionate — Other · Recommended · 2015 Calcipotriol With Betamethasone Dipropionate — Other · Recommended · 2025 Calcium Carbonate — Endocrinology · Recommended · 2019 Canagliflozin — Endocrinology · Recommended · 2013 Canakinumab — Other · Recommended · 2026 Cannabidiol — Neurology · Recommended · 2026 Caplacizumab — Haematology · Recommended · 2020 Carbohydrate, Fat, Vitamins, Minerals And Trace Elements — Metabolic · Recommended · 2020 Carbohydrate Formula With Minerals — Metabolic · Not recommended · 2016 Carfilzomib — Oncology · Recommended · 2022 Carglumic Acid — Metabolic · Not recommended · 2015 Cariprazine — Other · Recommended · 2020 Carmellose Sodium; Hypromellose — Other · Recommended · 2019 Carmellose Sodium With Glycerol And Hyaluronic Acid — Other · Recommended · 2023 Cationic Ophthalmic Emulsion, Preservative Free — Other · Recommended · 2020 Cefuroxime Axetil — Infectious disease · Recommended · 2015 Cemiplimab — Oncology · Recommended · 2023 Pneumococcal Conjugate Vaccine 13-Valent (13vpcv) And Pneumococcal Polysaccharide Vaccine 23-Valent (23vppv) — Other · Recommended · 2019 Ceritinib — Oncology · Recommended · 2016 Certolizumab Pegol — Other · Recommended · 2019 Cetrorelix — Other · Recommended · 2025 Cetuximab — Oncology · Recommended · 2024 Chlormethine Hydrochloride — Other · Recommended · 2023 Chorionic Gonadotrophin — Other · Recommended · 2017 Ciclosporin — Other · Recommended · 2026 Cinacalcet — Endocrinology · Recommended · 2019 Cipaglucosidase Alfa With Miglustat — Metabolic · Not recommended · 2025 Citrulline — Metabolic · Recommended · 2015 Cladribine — Neurology · Not recommended · 2023 Clobetasol Propionate — Other · Not recommended · 2024 Clostridium Botulinum Type A Toxin-Haemagglutinin Complex — Neurology · Recommended · 2020 Clostridium Botulinum Type A Toxin – Haemagglutinin Complex — Neurology · Recommended · 2019 Clozapine — Other · Recommended · 2018 Coal Tar Prepared — Other · Recommended · 2014 Cobicistat — Infectious disease · Not recommended · 2013 Vemurafenib + Cobimetinib — Oncology · Recommended · 2016 Collagenase Clostridium Histolyticum — Other · Not recommended · 2014 Corifollitropin Alfa — Other · Recommended · 2013 Crisaborole — Other · Deferred · 2020 Crizotinib — Oncology · Recommended · 2018 Dabigatran Etexilate — Cardiovascular · Recommended · 2012 Dabrafenib And Trametinib — Oncology · Recommended · 2025 Dabrafenib + Trametinib — Oncology · Recommended · 2019 Dabrafenib — Oncology · Recommended · 2013 Daclatasvir — Other · Not recommended · 2015 Daclizumab — Neurology · Recommended · 2016 Dactylis Glomerata With Poa Pratensis, Lolium Perenne, Anthoxanthum Odoratum And Phleum Pratense — Other · Not recommended · 2016 Dapagliflozin And Metformin Extended Release — Endocrinology · Recommended · 2015 Dapagliflozin — Endocrinology · Recommended · 2025 Dapagliflozin With Metformin — Endocrinology · Deferred · 2017 Dapagliflozin/Saxagliptin — Other · Deferred · 2017 Dapagliflozin With Sitagliptin — Endocrinology · Recommended · 2024 Dapsone — Other · Recommended · 2025 Daratumumab — Haematology · Recommended · 2025 Darbepoetin Alfa — Oncology · Recommended · 2019 Darolutamide — Oncology · Recommended · 2022 Darunavir With Cobicistat With Emtricitabine And Tenofovir Alafenamide — Infectious disease · Recommended · 2019 Darunavir + Cobicistat — Infectious disease · Recommended · 2016 Darunavir/Cobicistat — Infectious disease · Recommended · 2015 Dasatinib — Haematology · Recommended · 2019 Daunorubicin With Cytarabine (Liposomal) — Haematology · Recommended · 2023 Daunorubicin With Cytarabine — Haematology · Recommended · 2023 Liposomal Daunorubicin And Cytarabine — Haematology · Recommended · 2024 Decitabine With Cedazuridine — Haematology · Recommended · 2021 Decitabine + Cedazuridine — Haematology · Deferred · 2021 Deferasirox — Haematology · Recommended · 2020 Deferiprone — Other · Recommended · 2017 Degarelix — Oncology · Recommended · 2017 Delgocitinib — Other · Recommended · 2025 Denosumab — Endocrinology · Recommended · 2025 Desmopressin Acetate — Endocrinology · Recommended · 2025 Deucravacitinib — Other · Deferred · 2023 Dexamethasone — Other · Not recommended · 2018 Dienogest — Other · Recommended · 2024 Difelikefalin — Other · Recommended · 2023 Dimethyl Fumarate — Neurology · Recommended · 2019 Diroximel Fumarate — Neurology · Recommended · 2022 Docetaxel — Oncology · Recommended · 2017 Dolutegravir + Abacavir + Lamivudine — Infectious disease · Recommended · 2014 Dolutegravir/Rilpivirine — Infectious disease · Recommended · 2018 Dolutegravir With Lamivudine — Infectious disease · Recommended · 2020 Donanemab — Neurology · Recommended · 2025 Dorzolamide With Timolol — Other · Recommended · 2022 Dostarlimab — Oncology · Recommended · 2025 Drospirenone — Other · Recommended · 2024 Drospirenone With Ethinylestradiol — Other · Not recommended · 2024 Direct-Acting Antiviral (Daa) Regimens — Other · Not recommended · 2019 Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis And Haemophilus Influenzae Type B Conjugate Vaccine — Other · Recommended · 2022 Dtpa-Hepb-Ipv-Hib Vaccine — Other · Recommended · 2015 Diphtheria + Tetanus + Acellular Pertussis Vaccine — Other · Not recommended · 2014 Diphtheria, Tetanus, Acellular Pertussis Vaccine (Dtpa) — Other · Not recommended · 2016 Diphtheria And Tetanus Toxoids Combined With Pertussis Vaccine-Acellular — Other · Recommended · 2017 Dulaglutide — Endocrinology · Recommended · 2022 Dupilumab — Respiratory · Recommended · 2026 Durvalumab, Olaparib — Oncology · Recommended · 2024 Durvalumab — Oncology · Recommended · 2026 Durvalumab And Tremelimumab — Oncology · Recommended · 2025 Eculizumab — Neurology · Recommended · 2021 Edaravone — Neurology · Recommended · 2025 Efgartigimod Alfa — Neurology · Recommended · 2026 Eflornithine — Oncology · Recommended · 2025 Elacestrant — Oncology · Recommended · 2025 Elafibranor — Other · Recommended · 2025 Elexacaftor/Tezacaftor/Ivacaftor — Other · Recommended · 2022 Elexacaftor With Tezacaftor And With Ivacaftor, And Ivacaftor — Other · Recommended · 2025 Eliglustat — Metabolic · Recommended · 2015 Elosulfase Alfa — Metabolic · Not recommended · 2016 Elotuzumab — Oncology · Recommended · 2021 Elranatamab — Haematology · Other · 2025 Eltrombopag — Haematology · Recommended · 2023 Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide — Infectious disease · Recommended · 2015 Elvitegravir — Infectious disease · Not recommended · 2013 Empagliflozin — Endocrinology · Deferred · 2025 Empagliflozin/Metformin — Endocrinology · Recommended · 2015 Empagliflozin, Empagliflozin With Metformin, Linagliptin, Linagliptin With Metformin — Endocrinology · Recommended · 2017 Empagliflozin With Linagliptin — Endocrinology · Recommended · 2017 Encorafenib — Oncology · Recommended · 2025 Encorafenib; Binimetinib — Oncology · Recommended · 2018 Enfortumab Vedotin — Oncology · Recommended · 2024 Enoxaparin Sodium — Cardiovascular · Recommended · 2020 Enoxaparin — Cardiovascular · Recommended · 2025 Entrectinib — Oncology · Recommended · 2020 Enzalutamide — Oncology · Recommended · 2026 Epcoritamab — Haematology · Recommended · 2024 Eplerenone — Cardiovascular · Not recommended · 2025 Epoetin Lambda — Haematology · Recommended · 2017 Epoprostenol — Respiratory · Recommended · 2016 Eptinezumab — Neurology · Recommended · 2022 Erenumab — Neurology · Recommended · 2024 Eribulin Mesilate — Oncology · Recommended · 2013 Eribulin — Oncology · Recommended · 2016 Erlotinib — Oncology · Recommended · 2013 Ertugliflozin — Endocrinology · Recommended · 2018 Ertugliflozin With Sitagliptin — Endocrinology · Recommended · 2018 Escitalopram — Other · Recommended · 2014 Esketamine — Other · Recommended · 2024 Essential Amino Acids Formula With Vitamins And Minerals — Metabolic · Recommended · 2021 Estetrol With Drospirenone — Other · Not recommended · 2025 Estradiol; Progesterone; Estradiol And Progesterone Combination — Other · Recommended · 2024 Estradiol — Endocrinology · Recommended · 2024 Etanercept — Other · Recommended · 2025 Etonogestrel With Ethinylestradiol — Other · Deferred · 2025 Etrasimod — Other · Recommended · 2024 Everolimus — Neurology · Recommended · 2017 Evolocumab — Cardiovascular · Recommended · 2024 Exenatide — Endocrinology · Recommended · 2019 Ezetimibe And Atorvastatin — Cardiovascular · Recommended · 2013 Ezetimibe + Rosuvastatin — Cardiovascular · Recommended · 2014 Ezetimibe And Rosuvastatin — Cardiovascular · Recommended · 2013 Ezetimibe With Simvastatin — Cardiovascular · Not recommended · 2012 Ezetimibe + Simvastatin — Cardiovascular · Not recommended · 2014 Fampridine — Neurology · Not recommended · 2014 Faricimab — Other · Recommended · 2025 Febuxostat — Other · Not recommended · 2017 Fedratinib — Haematology · Recommended · 2025 Fenfluramine — Neurology · Recommended · 2024 Fentanyl Citrate — Other · Recommended · 2017 Fentanyl — Other · Not recommended · 2014 Ferric Carboxymaltose — Other · Recommended · 2018 Ferric Derisomaltose — Metabolic · Deferred · 2019 Fezolinetant — Other · Not recommended · 2025 Filgrastim — Haematology · Recommended · 2018 Finerenone — Endocrinology · Recommended · 2023 Fingolimod, Ofatumumab, Siponimod — Neurology · Recommended · 2024 Flucloxacillin — Infectious disease · Recommended · 2015 Fluocinolone Acetonide — Other · Recommended · 2020 Fluticasone Furoate — Respiratory · Recommended · 2019 Fluticasone Furoate / Umeclidinium / Vilanterol — Respiratory · Recommended · 2021 Fluticasone Propionate With Eformoterol Fumarate — Respiratory · Recommended · 2013 Fluticasone Propionate With Salmeterol — Respiratory · Recommended · 2023 Fluticasone Propionate With Formoterol Fumarate Dihydrate — Respiratory · Not recommended · 2018 Fluticasone Furoate + Vilanterol — Respiratory · Recommended · 2014 Fluticasone Propionate With Salmeterol Xinafoate — Respiratory · Not recommended · 2016 Fluticasone Furoate/Vilanterol — Respiratory · Not recommended · 2014 Fluticasone Furoate / Vilanterol Trifenatate — Respiratory · Recommended · 2014 Follitropin Alfa — Other · Not recommended · 2021 Follitropin Alfa With Lutropin Alfa — Other · Recommended · 2024 Follitropin Alfa + Lutropin Alfa; Lutropin Alfa — Other · Recommended · 2016 Follitropin Alfa And Lutropin Alfa — Other · Recommended · 2015 Follitropin Delta — Other · Recommended · 2017 Fosaprepitant — Oncology · Recommended · 2016 Foslevodopa With Foscarbidopa — Neurology · Recommended · 2024 Fosnetupitant With Palonosetron — Oncology · Recommended · 2020 Fremanezumab — Neurology · Recommended · 2022 Fruquintinib — Oncology · Recommended · 2024 Fulvestrant — Oncology · Recommended · 2020 Futibatinib — Oncology · Not recommended · 2025 Galcanezumab — Neurology · Recommended · 2022 Garadacimab — Other · Recommended · 2024 Gefitinib — Oncology · Not recommended · 2013 Gemcitabine — Oncology · Recommended · 2025 Gemtuzumab Ozogamicin — Haematology · Recommended · 2021 Gilteritinib — Haematology · Recommended · 2022 Givosiran — Other · Recommended · 2025 Glatiramer Acetate — Neurology · Recommended · 2022 Glecaprevir With Pibrentasvir — Other · Deferred · 2020 Glofitamab — Haematology · Recommended · 2025 Glucose Indicator Blood Strip — Endocrinology · Recommended · 2016 Glycine With Carbohydrate — Metabolic · Recommended · 2014 Glycomacropeptide And Essential Amino Acids With Vitamins And Minerals — Metabolic · Recommended · 2024 Glycomacropeptide Formula With Docosahexaenoic Acid And Low Phenylalanine — Metabolic · Recommended · 2019 Glycomacropeptide And Essential Amino Acids — Metabolic · Recommended · 2016 Glycomacropeptide Formula With Long Chain Polyunsaturated Fatty Acids And Docosahexaenoic Acid And Low In Phenylalanine — Metabolic · Recommended · 2026 Glycomacropeptide Formula With Long Chain Polyunsaturated Fatty Acids And Docosahexaenoic Acid And Low Phenylalanine — Metabolic · Recommended · 2017 Glycomacropeptide Formula With Amino Acids And Low Phenylalanine — Metabolic · Recommended · 2022 Glycomacropeptide Formula With Amino Acids, Vitamins, Minerals, Trace Elements, Carbohydrate, Fat And Low Phenylalanine — Metabolic · Recommended · 2022 Glycomacropeptide Formula With Docosahexaenoic Acid With Low Phenylalanine — Metabolic · Recommended · 2018 Glycopyrronium Bromide — Respiratory · Not recommended · 2015 Golimumab — Other · Recommended · 2018 Golimumab; Infliximab; Ustekinumab — Other · Deferred · 2014 Goserelin — Other · Recommended · 2017 Grazoprevir / Elbasvir — Other · Recommended · 2016 Grazoprevir With Elbasvir — Other · Deferred · 2018 Guanfacine — Neurology · Recommended · 2018 Guselkumab — Other · Recommended · 2025 Hepatitis B Surface Antigen Recombinant Vaccine — Other · Recommended · 2018 High Fat Formula With Vitamins, Minerals And Trace Elements And Low In Protein And Carbohydrate — Metabolic · Recommended · 2023 Inactivated Trivalent Influenza Vaccine (Split Virion), High Dose — Other · Not recommended · 2019 High Fat Formula With Vitamins, Minerals And Trace Elements And Low In Protein Carbohydrate — Metabolic · Recommended · 2016 Insect Allergen Extract - Honey Bee Venom, Yellow Jacket Venom, Paper Wasp Venom — Other · Recommended · 2016 House Dust Mite Allergen Extract — Other · Recommended · 2016 Human Papillomavirus 9-Valent Vaccine — Other · Recommended · 2022 Human Papillomavirus (Hpv) Types 16/18 Vaccine — Other · Recommended · 2015 Human Menopausal Gonadotrophin — Other · Recommended · 2022 Hyaluronic Acid With Polyethylene Glycol 400 With Propylene Glycol With Hydroxypropyl Guar — Other · Recommended · 2023 Hydrocortisone — Endocrinology · Recommended · 2021 Hydromorphone Hydrochloride — Other · Recommended · 2018 Hypromellose — Other · Recommended · 2021 Ibrutinib — Haematology · Recommended · 2024 Icatibant — Other · Recommended · 2017 Icosapent Ethyl — Cardiovascular · Recommended · 2024 Idelalisib — Haematology · Recommended · 2016 Imatinib — Haematology · Recommended · 2021 Inactivated Trivalent Influenza Vaccine (Surface Antigen), Adjuvanted — Other · Recommended · 2018 Inactivated Quadrivalent Influenza Vaccine (Split Virion) — Other · Recommended · 2020 Inactivated Trivalent Influenza Vaccine (Split Virion) — Other · Recommended · 2018 Inclisiran — Cardiovascular · Recommended · 2024 Incobotulinumtoxin A — Neurology · Recommended · 2024 Incobotulinumtoxina — Neurology · Recommended · 2026 Mometasone Furoate With Indacaterol And Glycopyrronium — Respiratory · Recommended · 2020 Indacaterol With Glycopyrronium — Respiratory · Recommended · 2014 Indacaterol + Glycopyrronium — Respiratory · Recommended · 2014 Mometasone Furoate With Indacaterol — Respiratory · Recommended · 2020 Infliximab — Other · Recommended · 2025 Influenza Vaccine, Adjuvanted Quadrivalent And Adjuvanted Trivalent — Other · Not recommended · 2019 Quadrivalent Influenza Vaccine — Other · Recommended · 2019 Quadrivalent Recombinant Influenza Vaccine — Other · Recommended · 2024 Cell-Cultured Quadrivalent Influenza Vaccine (Surface Antigen, Inactivated) — Other · Recommended · 2024 Inactivated Quadrivalent Influenza Vaccine — Other · Recommended · 2016 Ingenol Mebutate — Other · Not recommended · 2014 Inotuzumab Ozogamicin — Haematology · Not recommended · 2026 Insect Allergen Extract – Honey Bee Venom; Insect Allergen Extract – Paper Wasp Venom; Insect Allergen Extract – Yellow Jacket Venom — Other · Recommended · 2018 Insulin Degludec — Endocrinology · Recommended · 2025 Insulin Aspart — Endocrinology · Recommended · 2021 Insulin Degludec With Insulin Aspart — Endocrinology · Recommended · 2018 Insulin Detemir — Endocrinology · Recommended · 2007 Insulin Glargine — Endocrinology · Recommended · 2018 Insulin Glargine With Lixisenatide — Endocrinology · Recommended · 2019 Insulin Lispro — Endocrinology · Recommended · 2017 Ipilimumab — Oncology · Recommended · 2016 Iptacopan — Other · Recommended · 2025 Irinotecan (Nanoliposomal) — Oncology · Not recommended · 2024 Iron (As Sucrose) — Haematology · Recommended · 2014 Isotretinoin — Other · Recommended · 2019 Itraconazole — Infectious disease · Recommended · 2015 Ivabradine — Cardiovascular · Recommended · 2015 Ivacaftor — Other · Recommended · 2025 Ivermectin — Other · Recommended · 2014 Ivosidenib — Oncology · Recommended · 2024 Ixazomib — Haematology · Recommended · 2022 Ixekizumab — Other · Recommended · 2023 Lacosamide — Neurology · Recommended · 2021 Lanadelumab — Other · Recommended · 2024 Lanreotide Acetate — Endocrinology · Recommended · 2017 Lanreotide — Endocrinology · Recommended · 2026 Larotrectinib — Oncology · Not recommended · 2024 Latanoprost With Timolol Maleate — Other · Recommended · 2005 Ledipasvir/Sofosbuvir — Other · Recommended · 2015 Lenacapavir — Infectious disease · Recommended · 2023 Lenalidomide — Haematology · Recommended · 2023 Leniolisib — Other · Recommended · 2025 Lenvatinib — Other · Recommended · 2018 Letermovir — Infectious disease · Recommended · 2019 Leuprorelin — Endocrinology · Recommended · 2024 Leuprorelin Acetate — Endocrinology · Not recommended · 2022 Leuprorelin And Bicalutamide — Oncology · Recommended · 2016 Levodopa With Carbidopa Monohydrate — Neurology · Recommended · 2019 Levodopa With Carbidopa And Entacapone — Neurology · Not recommended · 2024 Levodopa With Carbidopa — Neurology · Recommended · 2016 Levonorgestrel — Other · Recommended · 2019 Lignocaine — Other · Recommended · 2015 Linagliptin With Metformin Hydrochloride — Endocrinology · Deferred · 2013 Linagliptin — Endocrinology · Recommended · 2016 Linezolid — Infectious disease · Recommended · 2013 Lipegfilgrastim — Oncology · Not recommended · 2016 Liraglutide — Endocrinology · Not recommended · 2018 Lisdexamfetamine — Neurology · Recommended · 2020 Lisdexamfetamine Dimesilate — Other · Recommended · 2014 Lixisenatide — Endocrinology · Recommended · 2014 Lorlatinib — Oncology · Deferred · 2021 Lumacaftor With Ivacaftor — Other · Recommended · 2023 Lumacaftor And Ivacaftor — Other · Not recommended · 2021 Lumacaftor/Ivacaftor — Other · Not recommended · 2019 Lumasiran — Other · Recommended · 2025 Lurasidone Hydrochloride — Other · Not recommended · 2014 Lurasidone — Other · Not recommended · 2015 Lurbinectedin — Oncology · Recommended · 2025 Lutropin Alfa — Other · Recommended · 2015 Macitentan — Cardiovascular · Recommended · 2014 Macitentan With Tadalafil — Respiratory · Recommended · 2024 Mannitol — Respiratory · Recommended · 2017 Maribavir — Infectious disease · Recommended · 2024 Mavacamten — Cardiovascular · Recommended · 2023 Mecasermin — Endocrinology · Deferred · 2022 Triglycerides, Long Chain; Triglycerides, Medium Chain — Metabolic · Recommended · 2017 Triglycerides, Medium Chain; Triglycerides, Long Chain — Metabolic · Not recommended · 2017 Medroxyprogesterone Acetate — Other · Recommended · 2023 Melatonin — Neurology · Recommended · 2021 Melatonin Prolonged Release — Neurology · Not recommended · 2021 Meningococcal Polysaccharide Conjugate Vaccine Serogroups A, C, W-135 And Y — Other · Recommended · 2018 Meningococcal (Groups A, C, W-135 And Y) Oligosaccharide Crm197 Conjugate Vaccine — Other · Recommended · 2023 Meningococcal Group B Vaccine (4cmenb) — Other · Not recommended · 2013 Meningococcal Polysaccharide Serogroups A, C, W-135 And Y Conjugate Vaccine — Other · Recommended · 2020 Mepolizumab — Respiratory · Recommended · 2026 Mercaptopurine — Haematology · Recommended · 2014 Mesalazine — Other · Recommended · 2020 Metformin And Saxagliptin — Endocrinology · Recommended · 2013 Metformin And Sitagliptin — Endocrinology · Recommended · 2013 Methadone — Other · Recommended · 2025 Methotrexate — Other · Recommended · 2018 Methotrexate (As Sodium) — Other · Recommended · 2024 Methoxsalen — Haematology · Recommended · 2021 Methylphenidate Hydrochloride Extended Release — Neurology · Not recommended · 2007 Methylphenidate Hydrochloride — Neurology · Recommended · 2022 Midazolam — Neurology · Recommended · 2023 Midazolam Maleate — Neurology · Recommended · 2022 Midostaurin — Haematology · Recommended · 2025 Mifepristone And Misoprostol — Other · Recommended · 2023 Migalastat — Other · Recommended · 2024 Milk Powder - Lactose Intolerance Formula — Other · Recommended · 2017 Milk Powder Synthetic Low Calcium — Metabolic · Recommended · 2020 Milk Powder Synthetic, Low Calcium Oral Powder — Metabolic · Recommended · 2024 Milk Protein And Fat Formula With Vitamins And Minerals, Carbohydrate Free — Metabolic · Recommended · 2020 Mirikizumab — Other · Recommended · 2023 Mirvetuximab Soravtansine — Oncology · Other · 2025 Mobocertinib — Oncology · Recommended · 2023 Modafinil, Armodafinil — Neurology · Recommended · 2022 Capecitabine, Megestrol, Toremifene, Vinorelbine — Oncology · Recommended · 2014 Mogamulizumab — Oncology · Not recommended · 2025 Molnupiravir — Infectious disease · Recommended · 2023 Momelotinib — Haematology · Recommended · 2024 Morphine Sulfate Pentahydrate — Other · Recommended · 2024 Morphine Hydrochloride — Other · Recommended · 2016 Meningococcal Group B Vaccine (Recombinant, Adsorbed) — Other · Not recommended · 2015 Meningococcal Group B Vaccine, Multicomponent (4cmenb) — Other · Recommended · 2019 Mupirocin — Infectious disease · Recommended · 2019 Nabiximols — Neurology · Recommended · 2020 Nadroparin Calcium — Cardiovascular · Recommended · 2016 Nalmefene — Other · Not recommended · 2015 Naloxone — Other · Recommended · 2019 Nandrolone Decanoate — Endocrinology · Not recommended · 2018 Naproxen And Esomeprazole — Other · Not recommended · 2013 Natalizumab — Neurology · Recommended · 2025 Nemolizumab — Other · Recommended · 2026 Neratinib — Oncology · Not recommended · 2019 Netupitant And Palonosetron — Oncology · Recommended · 2015 Netupitant/Palonosetron — Oncology · Recommended · 2015 Netupitant With Palonosetron — Oncology · Recommended · 2023 Nicotine — Other · Recommended · 2018 Nintedanib — Respiratory · Not recommended · 2024 Niraparib — Oncology · Recommended · 2023 Nirmatrelvir And Ritonavir — Infectious disease · Recommended · 2023 Nirsevimab — Other · Not recommended · 2025 Nitisinone — Metabolic · Not recommended · 2015 Nivolumab And Ipilimumab — Oncology · Not recommended · 2024 Nivolumab + Ipilimumab — Oncology · Recommended · 2022 Nivolumab — Oncology · Not recommended · 2026 Nivolumab Plus Ipilimumab — Oncology · Recommended · 2020 Nivolumab; Ipilimumab — Oncology · Recommended · 2025 Nusinersen — Neurology · Recommended · 2023 Obeticholic Acid — Other · Recommended · 2021 Obinutuzumab — Other · Recommended · 2026 Ocrelizumab — Neurology · Recommended · 2025 Ocriplasmin — Other · Recommended · 2019 Octreotide — Oncology · Recommended · 2019 Ocular Lubricants (Multiple Active Ingredients) — Other · Recommended · 2014 Odevixibat — Other · Recommended · 2026 Ofatumumab — Neurology · Not recommended · 2024 Olaparib — Oncology · Recommended · 2024 Olipudase Alfa — Other · Recommended · 2023 Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide — Cardiovascular · Recommended · 2013 Olodaterol — Respiratory · Not recommended · 2014 Omalizumab — Respiratory · Recommended · 2026 Omaveloxolone — Other · Not recommended · 2025 Onasemnogene Abeparvovec — Other · Not recommended · 2023 Ondansetron — Oncology · Recommended · 2020 Buprenorphine, Buprenorphine With Naloxone, Methadone — Other · Recommended · 2023 Opicapone — Neurology · Recommended · 2021 Osimertinib — Oncology · Recommended · 2025 Oxybutynin — Other · Recommended · 2023 Oxycodone Hydrochloride + Naloxone Hydrochloride — Other · Recommended · 2015 Oxycodone — Other · Not recommended · 2019 Oxycodone With Naloxone — Other · Recommended · 2016 Oxycodone Hydrochloride — Other · Not recommended · 2015 Ozanimod — Other · Recommended · 2022 Paclitaxel, Nanoparticle Albumin-Bound — Oncology · Recommended · 2019 Nab-Paclitaxel — Oncology · Not recommended · 2015 Paclitaxel-Nanoparticle Albumin Bound — Oncology · Recommended · 2014 Palbociclib — Oncology · Recommended · 2022 Paliperidone — Other · Recommended · 2025 Paliperidone Palmitate — Other · Recommended · 2022 Palopegteriparatide — Endocrinology · Recommended · 2025 Palovarotene — Other · Recommended · 2024 Pancreatic Extract — Other · Recommended · 2020 Panitumumab — Oncology · Recommended · 2015 Paracetamol — Other · Recommended · 2020 Paritaprevir With Ritonavir And Ombitasvir — Other · Recommended · 2016 Paritaprevir / Ritonavir / Ombitasvir / Dasabuvir — Other · Recommended · 2015 Patiromer — Endocrinology · Recommended · 2023 Patisiran — Other · Recommended · 2023 Pazopanib — Oncology · Recommended · 2013 Bosentan Monohydrate — Cardiovascular · Recommended · 2008 Clopidogrel Hydrogen Sulfate — Cardiovascular · Recommended · 2008 Duloxetine Hydrochloride — Other · Recommended · 2008 Efalizumab — Other · Recommended · 2008 Escitalopram Oxalate — Other · Recommended · 2008 Fludarabine Phosphate — Haematology · Recommended · 2008 Ibandronic Acid — Oncology · Recommended · 2008 Imatinib Mesylate — Haematology · Recommended · 2008 Lanthanum Carbonate Hydrate — Endocrinology · Deferred · 2008 Lercanidipine With Enalapril — Cardiovascular · Recommended · 2008 Levetiracetam — Neurology · Recommended · 2008 Maraviroc — Other · Deferred · 2012 Memantine Hydrochloride — Neurology · Recommended · 2008 Miglustat — Other · Not recommended · 2011 Modafinil — Neurology · Not recommended · 2008 Nilotinib — Haematology · Recommended · 2011 Oseltamivir — Infectious disease · Not recommended · 2008 Paricalcitol — Endocrinology · Not recommended · 2011 Pegfilgrastim — Oncology · Recommended · 2020 Poly-L-Lactic Acid — Other · Recommended · 2009 Pramipexole Hydrochloride — Neurology · Recommended · 2009 Raltegravir — Infectious disease · Deferred · 2017 Rotigotine — Neurology · Not recommended · 2008 Sibutramine Hydrochloride — Endocrinology · Not recommended · 2008 Sitagliptin Phosphate — Endocrinology · Recommended · 2008 Somatropin — Endocrinology · Recommended · 2023 Sorafenib Tosylate — Oncology · Not recommended · 2008 Sunitinib Malate — Oncology · Deferred · 2012 Tacrolimus — Other · Recommended · 2025 Tamsulosin Hydrochloride — Other · Recommended · 2010 Telbivudine — Other · Recommended · 2008 Tenofovir Disoproxil Fumarate — Other · Recommended · 2009 Teriparatide — Endocrinology · Recommended · 2025 Trastuzumab — Oncology · Recommended · 2021 Zoledronic Acid — Oncology · Recommended · 2023 Zoster Virus Vaccine Live (Oka/Merk) — Other · Recommended · 2008 Pegcetacoplan — Other · Recommended · 2026 Peginterferon Alfa-2a — Infectious disease · Recommended · 2017 Pegunigalsidase Alfa — Other · Recommended · 2025 Pegvaliase — Metabolic · Not recommended · 2026 Pegvisomant — Endocrinology · Recommended · 2019 Pemetrexed — Oncology · Recommended · 2023 Perampanel — Neurology · Recommended · 2017 Perfluorohexyloctane — Other · Recommended · 2018 Pertussis Vaccine-Acellular, Combined With Diphtheria And Tetanus Toxoids (Dtap) — Other · Recommended · 2015 Pertuzumab — Oncology · Recommended · 2025 Trastuzumab; Pertuzumab; Trastuzumab Emtansine — Oncology · Recommended · 2014 Pioglitazone — Endocrinology · Recommended · 2025 Pirfenidone — Respiratory · Recommended · 2018 Amino Acid Formula With Fat, Carbohydrate, Vitamins, Minerals And Long Chain Polyunsaturated Fatty Acids Without Phenylalanine And Supplemented With Docosahexaenoic Acid — Metabolic · Recommended · 2016 Amino Acid Formula With Carbohydrate, Vitamins, Minerals And Trace Elements Without Phenylalanine — Metabolic · Recommended · 2016 Plerixafor — Haematology · Recommended · 2013 Plitidepsin — Haematology · Not recommended · 2020 Pneumococcal Polysaccharide Conjugate 13-Valent — Other · Recommended · 2018 Pneumococcal Conjugate Vaccine, 13-Valent — Other · Recommended · 2016 Pneumococcal Conjugate Vaccine, 15-Valent — Other · Recommended · 2023 21-Valent Pneumococcal Conjugate Vaccine — Other · Recommended · 2025 Pneumococcal Polysaccharide Conjugate Vaccine, 13-Valent — Other · Not recommended · 2018 Polatuzumab Vedotin — Haematology · Not recommended · 2025 Polyethylene Glycol 400 With Propylene Glycol — Other · Recommended · 2025 Pomalidomide — Oncology · Recommended · 2023 Ponatinib — Haematology · Recommended · 2018 Posaconazole — Infectious disease · Recommended · 2015 Pralatrexate — Oncology · Recommended · 2017 Prasugrel — Cardiovascular · Recommended · 2024 Prednisolone With Phenylephrine — Other · Recommended · 2019 Pregabalin — Other · Deferred · 2021 Primidone — Neurology · Recommended · 2019 Progesterone — Other · Recommended · 2024 Propranolol — Other · Not recommended · 2017 Propylene Glycol — Other · Recommended · 2024 Protein Formula With Vitamins And Minerals, Low In Potassium, Phosphorus, Calcium, Chloride And Vitamin A — Metabolic · Recommended · 2020 Protein Formula With Carbohydrate, Fat, Vitamins, Minerals And Transforming Growth Factor Beta-2 — Other · Not recommended · 2020 Protein Formula With Carbohydrate, Fat, Fibre, Vitamins And Minerals — Metabolic · Not recommended · 2015 Protein Hydrolysate Formula With Medium Chain Triglycerides — Metabolic · Recommended · 2018 Quadrivalent Influenza Vaccine (Split Virion, Inactivated) — Other · Recommended · 2019 Quadrivalent Influenza Vaccine (Surface Antigen, Inactivated, Cell-Based) — Other · Recommended · 2022 Rabeprazole — Other · Recommended · 2022 Radium-223 Dichloride — Oncology · Recommended · 2017 Ramucirumab — Oncology · Not recommended · 2019 Ranibizumab — Other · Recommended · 2025 Ranolazine — Cardiovascular · Recommended · 2018 Ravulizumab — Neurology · Recommended · 2025 Raxtozinameran — Other · Deferred · 2025 Regorafenib — Oncology · Recommended · 2021 Relatlimab And Nivolumab — Oncology · Recommended · 2023 Relatlimab With Nivolumab — Oncology · Recommended · 2022 Relugolix With Estradiol And Norethisterone Acetate — Other · Recommended · 2024 Repotrectinib — Oncology · Recommended · 2025 Mrna-1345 — Other · Not recommended · 2025 Retifanlimab — Oncology · Recommended · 2025 Ribavirin — Other · Recommended · 2016 Ribociclib — Oncology · Recommended · 2025 Rifampicin — Infectious disease · Recommended · 2020 Rifaximin — Other · Not recommended · 2019 Riluzole — Neurology · Not recommended · 2026 Rimegepant — Neurology · Recommended · 2024 Riociguat — Cardiovascular · Deferred · 2016 Ripretinib — Oncology · Recommended · 2021 Risankizumab — Other · Recommended · 2023 Risdiplam — Other · Recommended · 2025 Risedronate Sodium — Endocrinology · Deferred · 2023 Risperidone — Other · Recommended · 2026 Rituximab — Haematology · Recommended · 2021 Rivaroxaban — Cardiovascular · Not recommended · 2024 Rivastigmine — Neurology · Recommended · 2015 Romidepsin — Oncology · Recommended · 2026 Romiplostim And Eltrombopag — Haematology · Recommended · 2022 Romosozumab — Endocrinology · Recommended · 2024 Rozanolixizumab — Neurology · Recommended · 2025 Rsv Pre-Fusion F Protein Vaccine (Rsvpref) — Other · Recommended · 2024 Respiratory Syncytial Virus Vaccine, Recombinant Pre-Fusion F Protein 3 Older Adult (Rsvpref3 Oa) — Other · Not recommended · 2024 Ruxolitinib — Haematology · Recommended · 2026 Sacituzumab Govitecan — Oncology · Not recommended · 2025 Sacubitril With Valsartan — Cardiovascular · Recommended · 2024 Sacubitril/Valsartan — Cardiovascular · Recommended · 2020 Safinamide — Neurology · Recommended · 2018 Salbutamol — Respiratory · Recommended · 2020 Sapropterin — Metabolic · Not recommended · 2022 Sarilumab — Other · Not recommended · 2018 Saxagliptin And Metformin Extended Release — Endocrinology · Recommended · 2015 Saxagliptin With Metformin — Endocrinology · Deferred · 2013 Saxagliptin — Endocrinology · Recommended · 2015 Sebelipase Alfa — Metabolic · Recommended · 2022 Secukinumab — Other · Recommended · 2023 Seladelpar — Other · Recommended · 2025 Selexipag — Cardiovascular · Recommended · 2020 Selinexor — Oncology · Recommended · 2022 Selpercatinib — Oncology · Recommended · 2026 Semaglutide — Cardiovascular · Not recommended · 2025 Sevelamer Carbonate — Endocrinology · Recommended · 2019 Sevelamer — Endocrinology · Recommended · 2017 Siltuximab — Other · Recommended · 2021 Simeprevir — Other · Recommended · 2016 Siponimod — Neurology · Recommended · 2024 Sitagliptin — Endocrinology · Not recommended · 2015 Sodium Phenylbutyrate — Metabolic · Recommended · 2019 Sodium Zirconium Cyclosilicate — Endocrinology · Recommended · 2024 Sofosbuvir With Velpatasvir — Infectious disease · Not recommended · 2017 Sofosbuvir — Other · Recommended · 2015 Sofosbuvir With Velpatasvir And Voxilaprevir — Other · Recommended · 2018 Somapacitan — Endocrinology · Recommended · 2023 Somatrogon — Endocrinology · Recommended · 2022 Sonidegib — Other · Not recommended · 2023 Sorafenib — Oncology · Not recommended · 2015 Sotatercept — Respiratory · Recommended · 2025 Sotorasib — Oncology · Recommended · 2022 Strontium Ranelate — Endocrinology · Not recommended · 2015 Sucroferric Oxyhydroxide — Endocrinology · Not recommended · 2015 Sunitinib — Oncology · Recommended · 2013 Tadalafil — Cardiovascular · Recommended · 2024 Tafamidis — Cardiovascular · Not recommended · 2026 Tafasitamab — Haematology · Recommended · 2025 Tagraxofusp — Haematology · Other · 2023 Talazoparib — Oncology · Recommended · 2024 Taliglucerase Alfa — Metabolic · Not recommended · 2014 Talimogene Laherparepvec — Oncology · Not recommended · 2016 Tamoxifen — Oncology · Recommended · 2016 Tapentadol — Other · Recommended · 2013 Tenofovir Disoproxil Fumarate With Emtricitabine / Tenofovir Disoproxil Maleate With Emtricitabine / Tenofovir Disoproxil Phosphate With Emtricitabine — Infectious disease · Recommended · 2020 Tebentafusp — Oncology · Recommended · 2023 Teduglutide — Other · Recommended · 2021 Tenofovir Alafenamide, Emtricitabine, And Rilpivirine — Infectious disease · Recommended · 2016 Bictegravir + Emtricitabine + Tenofovir Alafenamide — Infectious disease · Deferred · 2018 Emtricitabine + Tenofovir Alafenamide — Infectious disease · Recommended · 2016 Emtricitabine/Tenofovir Disoproxil Fumarate — Infectious disease · Not recommended · 2016 Tenofovir Disoproxil Maleate With Emtricitabine — Infectious disease · Recommended · 2017 Tenofovir With Emtricitabine — Infectious disease · Recommended · 2017 Tenofovir Disoproxil Fumarate / Emtricitabine — Infectious disease · Recommended · 2017 Tenofovir Disoproxil Fumarate With Emtricitabine And Efavirenz; Tenofovir Disoproxil Fumarate With Emtricitabine And Rilpivirine; Tenofovir Disoproxil Fumarate With Emtricitabine, Elvitegravir And Cobicistat — Infectious disease · Deferred · 2019 Tepotinib — Oncology · Recommended · 2021 Teprotumumab — Other · Recommended · 2025 Terbutaline — Respiratory · Recommended · 2020 Teriflunomide — Neurology · Not recommended · 2016 Testosterone — Other · Not recommended · 2025 Tetracosactide — Neurology · Deferred · 2021 Tetracosactrin — Neurology · Recommended · 2017 Tezacaftor With Ivacaftor — Other · Recommended · 2019 Tezepelumab — Respiratory · Recommended · 2025 Oxycodone, Tramadol, Codeine, Hydromorphone, Morphine, Tapentadol, Buprenorphine, Fentanyl — Other · Recommended · 2019 Thiazolidinediones, Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Co-Transporter 2 Inhibitors — Other · Deferred · 2014 Thyroxine Sodium — Endocrinology · Not recommended · 2016 Ticagrelor — Cardiovascular · Not recommended · 2023 Tildrakizumab — Other · Not recommended · 2026 Tiotropium — Respiratory · Recommended · 2024 Tiotropium Bromide — Respiratory · Recommended · 2015 Tiotropium Bromide Plus Olodaterol Hydrochloride — Respiratory · Recommended · 2015 Tiotropium With Olodaterol — Respiratory · Recommended · 2024 Tiotropium Bromide With Olodaterol Hydrochloride — Respiratory · Recommended · 2017 Tirzepatide — Endocrinology · Recommended · 2025 Tislelizumab — Oncology · Recommended · 2024 Tixagevimab And Cilgavimab — Infectious disease · Recommended · 2022 Tobramycin — Infectious disease · Recommended · 2013 Tocilizumab — Other · Not recommended · 2025 Tofacitinib — Other · Recommended · 2024 Tofersen — Neurology · Recommended · 2026 Tolvaptan — Other · Recommended · 2019 Topotecan — Oncology · Recommended · 2020 Toripalimab — Oncology · Recommended · 2025 Trabectedin — Oncology · Recommended · 2021 Tramadol Hydrochloride With Paracetamol — Other · Not recommended · 2018 Trametinib — Oncology · Recommended · 2016 Trastuzumab Deruxtecan — Oncology · Recommended · 2026 Trastuzumab Emtansine — Oncology · Recommended · 2019 Trientine Tetrahydrochloride — Other · Recommended · 2022 Trientine Dihydrochloride — Metabolic · Recommended · 2023 Trifluridine With Tipiracil — Oncology · Recommended · 2019 Triglycerides Medium Chain Formula — Metabolic · Recommended · 2020 Triglycerides Long Chain With Glucose Polymer — Metabolic · Recommended · 2014 Triglycerides, Long Chain With Glucose Polymer — Metabolic · Recommended · 2024 Triglycerides Medium Chain And Long Chain With Glucose Polymer — Metabolic · Recommended · 2020 Medium Chain Triglycerides; Protein Formula With Carbohydrate, Fat, Vitamins And Minerals — Metabolic · Recommended · 2019 Medium Chain Triglycerides Formula — Metabolic · Recommended · 2016 Triglycerides, Medium Chain — Metabolic · Recommended · 2022 Triptorelin — Endocrinology · Recommended · 2021 Triptorelin Acetate — Other · Recommended · 2016 Trivalent Influenza Vaccine — Other · Recommended · 2014 Tucatinib — Oncology · Recommended · 2025 Tyrosine With Carbohydrate — Metabolic · Recommended · 2019 Ublituximab — Neurology · Recommended · 2025 Ulipristal Acetate — Other · Not recommended · 2017 Umeclidinium Bromide — Respiratory · Recommended · 2014 Umeclidinium Bromide And Vilanterol Trifenatate — Respiratory · Not recommended · 2014 Umeclidinium + Vilanterol — Respiratory · Not recommended · 2014 Upadacitinib — Other · Recommended · 2026 Ursodeoxycholic Acid — Other · Recommended · 2023 Ustekinumab — Other · Recommended · 2026 Vanzacaftor/Tezacaftor/Deutivacaftor — Other · Recommended · 2025 Varenicline — Other · Recommended · 2017 Varicella Zoster Virus Recombinant Vaccine — Other · Recommended · 2023 Recombinant Varicella Zoster Virus Glycoprotein E Antigen (As01b Adjuvanted) Vaccine — Other · Recommended · 2018 Vedolizumab — Other · Deferred · 2025 Velmanase Alfa — Metabolic · Recommended · 2025 Vemurafenib — Oncology · Deferred · 2013 Venetoclax — Haematology · Recommended · 2021 Vericiguat — Cardiovascular · Recommended · 2022 Verteporfin — Other · Recommended · 2005 Vildagliptin/Metformin — Endocrinology · Not recommended · 2013 Vildagliptin — Endocrinology · Recommended · 2017 Vinflunine — Oncology · Not recommended · 2017 Vismodegib — Oncology · Recommended · 2017 Vitamins, Minerals And Trace Elements With Carbohydrate — Metabolic · Recommended · 2020 Vitamins, Minerals And Trace Elements Formula — Metabolic · Recommended · 2017 Vorasidenib — Oncology · Recommended · 2026 Voriconazole — Infectious disease · Recommended · 2014 Vorinostat — Oncology · Recommended · 2017 Vortioxetine — Other · Not recommended · 2014 Vosoritide — Other · Recommended · 2022 Vutrisiran — Other · Recommended · 2024 Warfarin — Cardiovascular · Not recommended · 2016 Whey Protein Formula With Medium Chain Triglycerides, Carbohydrate, Vitamins And Minerals — Metabolic · Deferred · 2016 Whey Protein Formula Supplemented With Amino Acids, Vitamins And Minerals, And Low In Protein, Phosphate, Potassium And Lactose — Metabolic · Recommended · 2020 Zanubrutinib — Haematology · Recommended · 2025 Zilucoplan — Neurology · Not recommended · 2025 Zolbetuximab — Oncology · Recommended · 2025 Zoster Virus Vaccine Live — Other · Deferred · 2014 Adefovir Dipivoxil — Other · Recommended · 2007 Anastrozole, Everolimus, Exemestane, Goserelin, Letrozole — Oncology · Recommended · 2014 Cinacalcet Hydrochloride — Endocrinology · Not recommended · 2009 Darunavir — Other · Not recommended · 2010 Dutasteride — Other · Not recommended · 2009 Galsulfase — Other · Not recommended · 2007 Human Papillomavirus (Types 16 And 18) Recombinant, As04 Adjuvanted Vaccine — Other · Recommended · 2007 Idursulfase — Other · Not recommended · 2007 Influenza Vaccine — Other · Not recommended · 2007 Ivabradine Hydrochloride — Cardiovascular · Not recommended · 2009 Lapatinib Ditosylate — Oncology · Not recommended · 2007 Lapatinib Ditosylate Monohydrate — Oncology · Not recommended · 2007 Macrogol 3350 — Other · Recommended · 2007 Methyl 5-Aminolevulinate Hydrochloride — Other · Not recommended · 2008 Ziprasidone Hydrochloride — Other · Recommended · 2008 Pioglitazone Hydrochloride — Other · Recommended · 2007 Quetiapine Fumarate — Other · Not recommended · 2009 Rosiglitazone Maleate — Other · Not recommended · 2007 Sevelamer Hydrochloride — Other · Recommended · 2007 Sitaxentan Sodium — Cardiovascular · Recommended · 2007 Solifenacin — Other · Recommended · 2010 Tazarotene — Other · Not recommended · 2007 Terbinafine — Other · Recommended · 2007 Tsp (Tamarindus Indica Seed Polysaccharide) — Other · Recommended · 2007 Varenicline Tartrate — Other · Recommended · 2009 Zonisamide — Neurology · Recommended · 2007 Pcv15 — Infectious disease · Recommended · 2021 Abiraterone — Oncology · Recommended · 2012 Adapalene With Benzoyl Peroxide — Other · Recommended · 2010 Agalsidase Alfa — Other · Not recommended · 2009 Agomelatine — Other · Not recommended · 2012 Alendronate Sodium With Colecalciferol — Endocrinology · Recommended · 2006 Alendronate Sodium, Tablet — Endocrinology · Recommended · 2006 Aliskiren — Cardiovascular · Not recommended · 2010 Ambrisentan — Respiratory · Recommended · 2009 Amino Acid Formula With Fat, Carbohydrate Without Methionine — Metabolic · Recommended · 2019 Amlodipine Besylate With Atorvastatin Calcium — Cardiovascular · Recommended · 2006 Amlodipine (As Besylate) With Valsartan And Hydrochlorothiazide — Cardiovascular · Recommended · 2010 Anecortave Acetate — Other · Recommended · 2006 Asenapine — Other · Recommended · 2011 Atomoxetine Hydrochloride — Neurology · Recommended · 2008 Aztreonam — Respiratory · Recommended · 2012 Bimatoprost With Timolol Maleate — Other · Recommended · 2009 Boceprevir — Other · Recommended · 2012 Boceprevir And Ribavirin And Peginterferon Alfa-2b — Other · Not recommended · 2012 Buprenorphine Hydrochloride With Naloxone Hydrochloride — Other · Recommended · 2005 Capecitabine — Oncology · Recommended · 2011 Capivasertib — Oncology · Recommended · 2024 Carmustine — Oncology · Not recommended · 2008 Carmustine, Implant — Oncology · Recommended · 2005 Cilostazol — Other · Not recommended · 2010 Ciprofloxacin, Ear Drops — Other · Recommended · 2006 Clindamycin Phosphate With Benzoyl Peroxide, Gel — Other · Not recommended · 2009 Clostridium Botulinum Type A Toxin Haemagglutinin Complex — Neurology · Recommended · 2011 Colistimethate Sodium — Respiratory · Not recommended · 2011 Calcipotriol With Betamethasone Dipropionate, Ointment — Other · Recommended · 2009 Dabigatran Etexilate Mesilate — Other · Deferred · 2009 Dalteparin Sodium — Other · Recommended · 2010 Dorzolamide Hydrochloride With Timolol Maleate, Eye Drops — Other · Recommended · 2012 Doxorubicin Hydrochloride, Pegylated Liposomal — Haematology · Not recommended · 2008 Dronedarone Hydrochloride — Cardiovascular · Not recommended · 2010 Dutasteride With Tamsulosin Hydrochloride — Other · Recommended · 2010 Eletriptan Hydrobromide — Other · Recommended · 2010 Eltrombopag Olamine — Haematology · Not recommended · 2010 Entecavir — Other · Recommended · 2006 Epoprostenol Sodium — Respiratory · Recommended · 2011 Esomeprazole Magnesium Trihydrate — Other · Recommended · 2005 Etoricoxib — Other · Not recommended · 2008 Exemestane — Oncology · Recommended · 2006 Ezetimibe — Cardiovascular · Recommended · 2010 Famciclovir — Other · Recommended · 2006 Fentanyl, Transdermal Patch — Other · Recommended · 2006 Fingolimod — Neurology · Recommended · 2019 Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine — Other · Recommended · 2011 Glucosamine Hydrochloride — Other · Not recommended · 2006 Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine — Other · Recommended · 2011 Hydroxyethyl Starch 130/0.4 — Other · Recommended · 2009 Hylan G-F 20 — Other · Not recommended · 2006 Imiquimod, Cream — Other · Not recommended · 2009 Imiquimod — Other · Not recommended · 2008 Indacaterol Maleate — Respiratory · Not recommended · 2010 Indacaterol — Respiratory · Recommended · 2011 Influenza Vaccine, Injection — Other · Recommended · 2009 Insulin Glulisine — Endocrinology · Recommended · 2007 Interferon Beta-1b — Neurology · Not recommended · 2007 Ferrous Fumurate With Folic Acid — Other · Recommended · 2006 Lanthanum Carbonate — Other · Not recommended · 2007 Leflunomide — Other · Recommended · 2007 Letrozole — Oncology · Recommended · 2007 Levodopa With Carbidopa Monohydrate, Intestinal Gel — Neurology · Not recommended · 2009 Levonorgestrel, Intrauterine Drug Delivery System — Other · Recommended · 2007 Losartan — Cardiovascular · Recommended · 2010 Lumiracoxib — Other · Recommended · 2005 Methoxyflurane — Other · Recommended · 2008 Methyl Aminolevulinate — Oncology · Not recommended · 2005 Methylnaltrexone Bromide — Other · Recommended · 2009 Milnacipran — Other · Not recommended · 2012 Montelukast Sodium — Respiratory · Recommended · 2009 Moxonidine — Cardiovascular · Recommended · 2006 Mycophenolic Acid — Other · Recommended · 2012 Mycophenolate Sodium — Other · Recommended · 2011 Nebivolol Hydrochloride — Cardiovascular · Recommended · 2009 Nicotine, Transdermal Patch — Other · Recommended · 2010 Nicotinic Acid — Cardiovascular · Not recommended · 2007 Olanzapine Pamoate Monohydrate — Other · Recommended · 2009 Olmesartan Medoxomil With Hydrochlorothiazide — Cardiovascular · Recommended · 2007 Olmesartan Medoxomil — Cardiovascular · Recommended · 2005 Olmesartan Medoxomil With Amlodipine — Cardiovascular · Recommended · 2010 Omega-3-Acid Ethyl Esters — Cardiovascular · Not recommended · 2010 Oxycodone Hydrochloride And Naloxone Hydrochloride Dihydrate — Other · Not recommended · 2010 Oxycodone Hydrochloride With Naloxone Hydrochloride Dihydrate — Other · Recommended · 2010 Paclitaxel — Oncology · Recommended · 2006 Palonosetron Hydrochloride — Oncology · Recommended · 2010 Peginterferon Alfa-2b — Other · Recommended · 2005 Pemetrexed Disodium — Oncology · Not recommended · 2005 Perindopril Arginine With Amlodipine Besylate — Cardiovascular · Recommended · 2010 Pertussis Vaccine Acellular With Diphtheria And Tetanus Toxoids, Adsorbed — Other · Recommended · 2006 Adacel — Other · Not recommended · 2011 Pimecrolimus — Other · Recommended · 2006 Pneumococcal Polysaccharide Conjugate Vaccine — Other · Recommended · 2009 Pramipexole — Neurology · Not recommended · 2006 Prucalopride — Other · Not recommended · 2012 Ramipril With Felodipine — Cardiovascular · Recommended · 2007 Rasagiline — Neurology · Recommended · 2012 Peginterferon Alfa-2a, Ribavirin — Other · Recommended · 2010 Ribavirin And Peginterferon Alfa-2b — Other · Recommended · 2011 Romiplostim — Haematology · Recommended · 2010 Ropinirole — Neurology · Not recommended · 2006 Rosiglitazone Maleate With Metformin Hydrochloride — Other · Recommended · 2006 Rosuvastatin Calcium — Cardiovascular · Recommended · 2006 Human Rotavirus Vaccine — Other · Recommended · 2006 Rotavirus Vaccine — Other · Not recommended · 2006 Rotavirus Vaccine, Live, Oral Liquid, Pentavalent — Other · Recommended · 2006 Salbutamol Sulfate — Respiratory · Not recommended · 2010 Sapropterin Dihydrochloride — Metabolic · Recommended · 2011 Sertindole — Other · Not recommended · 2011 Sildenafil Citrate — Respiratory · Recommended · 2006 Sitagliptin With Simvastatin — Endocrinology · Recommended · 2012 Tafluprost — Other · Recommended · 2012 Telaprevir — Other · Recommended · 2012 Telmisartan With Amlodipine — Cardiovascular · Recommended · 2011 Temsirolimus — Oncology · Not recommended · 2008 Tenofovir Disoproxil Fumarate With Emtricitabine — Other · Recommended · 2005 Tenofovir Disoproxil Fumarate With Emtricitabine And Rilpivirine Hydrochloride — Other · Recommended · 2011 Testosterone Undecanoate — Endocrinology · Recommended · 2005 Thalidomide — Oncology · Recommended · 2009 Thyrotropin Alfa — Endocrinology · Recommended · 2007 Tipranavir — Infectious disease · Recommended · 2007 Tobramycin, Solution For Inhalation — Respiratory · Recommended · 2011 Topiramate — Neurology · Recommended · 2007 Trandolapril With Verapamil — Cardiovascular · Not recommended · 2005 Trandolapril With Verapamil Hydrochloride-Sr — Cardiovascular · Recommended · 2006 Travoprost With Timolol Maleate, Eye Drops — Other · Recommended · 2007 Travoprost With Timolol Maleate — Other · Not recommended · 2005 Treprostinil Sodium — Cardiovascular · Recommended · 2005 Valsartan With Hydrochlorothiazide — Cardiovascular · Recommended · 2008 Amlodipine Besylate With Valsartan — Cardiovascular · Recommended · 2008 Velaglucerase Alfa — Other · Not recommended · 2012 Vinorelbine Tartrate — Oncology · Recommended · 2006 Vinorelbine — Oncology · Not recommended · 2012 Whey Protein Formula Supplemented With Amino Acids, Long Chain Polyunsaturated Fatty Acids, Vitamins And Minerals, Low In Protein, Phosphate, Potassium And Lactose — Other · Recommended · 2020 Alefacept — Other · Not recommended · 2005 Atazanavir/Cobicistat — Infectious disease · Recommended · 2015 Cerliponase Alfa — Other · Recommended · 2018 Cobicistat + Elvitegravir + Emtricitabine + Tenofovir — Infectious disease · Recommended · 2013 Deutetrabenazine — Neurology · Not recommended · 2021 Dolutegravir — Infectious disease · Recommended · 2013 Tenofovir Alafenamide / Emtricitabine / Rilpivirine — Infectious disease · Not recommended · 2016 Eslicarbazepine Acetate — Neurology · Not recommended · 2021 Estradiol With Progesterone — Other · Not recommended · 2025 Etravirine — Infectious disease · Recommended · 2009 Fosnetupitant/Palonosetron — Oncology · Recommended · 2023 Glycopyrronium — Other · Not recommended · 2025 Gonadotrophin, Menopausal Human, Highly Purified — Other · Not recommended · 2016 Lebrikizumab — Other · Recommended · 2024 Linzagolix — Other · Not recommended · 2024 Osilodrostat — Endocrinology · Recommended · 2024 Pasireotide — Endocrinology · Recommended · 2015 Desvenlafaxine Succinate — Other · Recommended · 2008 Peginterferon Beta-1a — Neurology · Recommended · 2014 Respiratory Syncytial Virus Vaccine, Recombinant Pre-Fusion F Protein — Other · Deferred · 2024 Selumetinib — Other · Recommended · 2024 Stiripentol — Neurology · Recommended · 2020 Tenofovir Alafenamide / Emtricitabine — Infectious disease · Recommended · 2016 Tenofovir Alafenamide — Other · Recommended · 2017 Respiratory Syncytial Virus Vaccine, Recombinant, Pre-Fusion F Protein 3, Older Adult — Other · Not recommended · 2026 Avacincaptad Pegol — Other · Recommended · 2026 Loncastuximab Tesirine — Haematology · Recommended · 2026 Mrna-1273 — Other · Not recommended · 2026 Tarlatamab — Oncology · Recommended · 2026 Teclistamab — Oncology · Recommended · 2026 Abemaciclib — $46M government benefit · 2024 Acalabrutinib — $65M government benefit · 2024 Adalimumab — $246M government benefit · 2024 Aflibercept — $414M government benefit · 2024 Atezolizumab — $274M government benefit · 2024 Avelumab — $57M government benefit · 2024 Bevacizumab — $63M government benefit · 2024 Pembrolizumab — $1.1B government benefit · 2024 Cemiplimab — $215M government benefit · 2024 Daratumumab — $335M government benefit · 2024 Darbepoetin Alfa — $79M government benefit · 2024 Darolutamide — $59M government benefit · 2024 Denosumab — $291M government benefit · 2024 Dupilumab — $366M government benefit · 2024 Durvalumab — $227M government benefit · 2024 Enzalutamide — $158M government benefit · 2024 Etanercept — $89M government benefit · 2024 Faricimab — $125M government benefit · 2024 Golimumab — $87M government benefit · 2024 Goserelin — $53M government benefit · 2024 Guselkumab — $149M government benefit · 2024 Ibrutinib — $82M government benefit · 2024 Infliximab — $88M government benefit · 2024 Ipilimumab — $307M government benefit · 2024 Lenalidomide — $85M government benefit · 2024 Nivolumab — $875M government benefit · 2024 Obinutuzumab — $55M government benefit · 2024 Ocrelizumab — $225M government benefit · 2024 Osimertinib — $163M government benefit · 2024 Palbociclib — $84M government benefit · 2024 Pertuzumab — $69M government benefit · 2024 Ranibizumab — $93M government benefit · 2024 Ravulizumab — $73M government benefit · 2024 Ribociclib — $95M government benefit · 2024 Risankizumab — $97M government benefit · 2024 Ruxolitinib — $80M government benefit · 2024 Secukinumab — $104M government benefit · 2024 Semaglutide — $285M government benefit · 2024 Ustekinumab — $436M government benefit · 2024 Vedolizumab — $153M government benefit · 2024 Venetoclax — $74M government benefit · 2024 Zanubrutinib — $77M government benefit · 2024 Abiraterone — $53M government benefit · 2024 UMAP over decision-profile embeddings · one point per drug · 1,014 drugs · drag to pan · scroll to zoom · double-click a drug to zoom to its neighbourhood
Spend terrain table — the PBS top-expenditure list · 2024